NPI registry status
Active
2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1720248305 MD PHD
Verify on CMS → James Earl, MD PHD
Retina Specialist (Ophthalmology) Physician in Boise, Idaho.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 983 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
749
Medicare Part D claims · 239 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 593
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
70/100
▼ 14 pts below national avg 83.5 · Mid-tier
Industry payments
$421.47
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
James Earl, MD PHD reported a CMS MIPS final score of 70/100 - below the 83.5 national average - and filed 749 Medicare Part D claims in 2024.
- 70/100
- MIPS score · -13 vs avg
- 749
- Part D claims, 2024
- 63%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about James Earl, MD PHD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720248305), first enumerated 06/17/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 749 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 70/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$421.47 in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720248305 · Retina Specialist (Ophthalmology) Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-LOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1720248305
- ENUM-MID 2008
- TAX-NARROW 983
- MIPS-LOW 70/100
- RX-LIGHT 749
- BOOK-THIN 3 in Idaho
- PHOTO-FINISH Anita Agarwal · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Earl · this prov…
Earl · this provider
70 MIPS pts
- Malini Pasricha …
Malini Pasricha
70 MIPS pts
- Anita Agarwal · …
Anita Agarwal
70 MIPS pts
- Daniel Gealy · n…
Daniel Gealy
70 MIPS pts
- Georgia Kamboj ·…
Georgia Kamboj
70 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
James Earl, MD PHD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
70 ≥ 9th percentile 9% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where James Earl, MD PHD sits
This provider among retina specialist (ophthalmology) physician peers
Across the 573 retina specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, James Earl, MD PHD writes more Part D claims than 75% of them and scores higher on MIPS quality than 3% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one retina specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is James Earl, MD PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
James Earl, MD PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James Earl, MD PHD?
Below national averagePrimary specialty
Retina Specialist (Ophthalmology) Physician
Medicare Part D claims
749 26% vs specialty avg
MIPS final score
70/100 13.5 pts vs avg
Specialty distribution in Idaho
How Retina Specialist (Ophthalmology) Physician compares to other specialties among Idaho providers
Medicare quality performance, MIPS
James Earl, MD PHD's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 70/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720248305 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | MD PHD |
| Gender | Male |
| NPI Issued | 06/17/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
70
Final Score
Measured-score avg: 83.5
100
Quality
0
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where James Earl, MD PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Retina Specialists OF Idaho Partners PLLC
Boise, ID
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for James Earl, MD PHD. Source: openpaymentsdata.cms.gov.
Total received
$421
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
James Earl, MD PHD - brand share 37.0%
Retina Specialist (Ophthalmology) Physician average
37% brand-name claims vs 63% generic, on 749 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
749
Total Claims
$25K
Total Drug Cost
239
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,037.333
- Total Day Supply
- 25,267
- Brand vs Generic
- 37% brand / 63% generic
- Brand Drug Cost
- $19K
- Generic Drug Cost
- $6K
- Opioid Claims
- 56 (7.5% rate)
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.48
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 17, 65-74: 116, 75-84: 75, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What James Earl, MD PHD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prednisolone Acetate
Prednisolone Acetate
211 claims
- Timolol Maleate
Timolol Maleate
108 claims
- Ofloxacin
Ofloxacin
103 claims
- Latanoprost 63
Latanoprost
63 claims
- Brimonidine Tartrate 58
Brimonidine Tartrate
58 claims
- Acetaminophen-Code… 44
Acetaminophen-Codeine
44 claims
- Dorzolamide Hcl 44
Dorzolamide Hcl
44 claims
- Dorzolamide-Timolol 21
Dorzolamide-Timolol
21 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 211 |
| Timolol Maleate | 108 |
| Ofloxacin | 103 |
| Latanoprost | 63 |
| Brimonidine Tartrate | 58 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 44 |
| Dorzolamide Hcl | 44 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 21 |
| Ketorolac Tromethamine | 17 |
| Tramadol Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Retina Specialist (Ophthalmology) Physician in ID →
All providers in Idaho →
Compare specialties →
Retina Specialist (Ophthalmology) Physician Overview
How James Earl, MD PHD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
983
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
593
Avg Claims per Provider
James Earl, MD PHD's 749 claims are above the specialty average of 593.
Nationwide Retina Specialist (Ophthalmology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Earl, both outside Idaho so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (70 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Retina Specialist (Ophthalmology) Physician Providers in Idaho
Other clinicians with the same primary specialty enrolled in Idaho, drawn from the same CMS NPPES roster as Earl.
One of 3 Retina Specialist (Ophthalmology) Physician providers enrolled in Idaho, 2 are shown here.
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is James Earl, MD PHD's specialty? ▼
James Earl, MD PHD specializes in Retina Specialist (Ophthalmology) Physician and practices in Boise, Idaho. Credentials: MD PHD.
How much does James Earl, MD PHD prescribe under Medicare Part D? ▼
In 2024, James Earl, MD PHD wrote 749 Medicare Part D claims totaling $25K in drug costs for 239 beneficiaries.
What is James Earl, MD PHD's Medicare quality score? ▼
James Earl, MD PHD has a CMS MIPS Final Score of 70/100 (Quality: 100). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is James Earl, MD PHD located? ▼
James Earl, MD PHD is located at 13923 W. WAINWRIGHT DR STE 301, Boise, ID, 83713. Phone: (208) 938-5624.
What is James Earl, MD PHD's NPI number? ▼
James Earl, MD PHD's National Provider Identifier (NPI) is 1720248305, issued on 06/17/2008.
Does James Earl, MD PHD prescribe more brand-name or generic drugs? ▼
James Earl, MD PHD's prescribing is 37% brand-name and 63% generic drugs by claim count, with $19K in brand drug costs.
Does James Earl, MD PHD prescribe opioids? ▼
Yes, James Earl, MD PHD had 56 opioid claims in 2024 with an opioid prescribing rate of 7.5%.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 983 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 593 Medicare Part D claims per year.
What drugs does James Earl, MD PHD prescribe most often? ▼
Based on 2024 Medicare Part D data, James Earl, MD PHD's most frequently prescribed drugs include Prednisolone Acetate, Timolol Maleate, Ofloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does James Earl, MD PHD accept Medicare? ▼
James Earl, MD PHD appears in CMS Medicare data with 749 Part D claims and 239 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify James Earl, MD PHD's credentials? ▼
James Earl, MD PHD's NPI is 1720248305 with credentials MD PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.